These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11794545)

  • 1. NMDA-type glutamatergic modulation in dopaminergic activation measured by apomorphine-induced cage climbing behaviors.
    Jang CG; Lee SY
    Arch Pharm Res; 2001 Dec; 24(6):613-7. PubMed ID: 11794545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice.
    Kim HS; Rhee GS; Jung JY; Lee JH; Jang CG; Park WK
    Life Sci; 1996; 58(17):1397-402. PubMed ID: 8622565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA receptor antagonists inhibit apomorphine-induced climbing behavior not only in intact mice but also in reserpine-treated mice.
    Kim HS; Rhee GS; Oh S; Park WK
    Behav Brain Res; 1999 Apr; 100(1-2):135-42. PubMed ID: 10212060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.
    Kim HS; Jang CG
    Brain Res Bull; 1997; 44(3):221-7. PubMed ID: 9323434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of ionotropic glutamate receptor-mediated nitric oxide production in vivo in rats.
    Bhardwaj A; Northington FJ; Ichord RN; Hanley DF; Traystman RJ; Koehler RC
    Stroke; 1997 Apr; 28(4):850-6; discussion 856-7. PubMed ID: 9099207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
    Mathé JM; Nomikos GG; Schilström B; Svensson TH
    J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: involvement of supraspinal NMDA but not non-NMDA receptors.
    Suh HW; Song DK; Choi YS; Kim YH
    Life Sci; 1995; 56(8):PL181-5. PubMed ID: 7869834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the prelimbic medial prefrontal cortex induces anxiety-like behaviors via N-Methyl-D-aspartate receptor-mediated glutamatergic neurotransmission in mice.
    Saitoh A; Ohashi M; Suzuki S; Tsukagoshi M; Sugiyama A; Yamada M; Oka J; Inagaki M; Yamada M
    J Neurosci Res; 2014 Aug; 92(8):1044-53. PubMed ID: 24752881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MK-801 and CNQX on various neurotoxic responses induced by kainic acid in mice.
    Lee JK; Choi SS; Lee HK; Han KJ; Han EJ; Suh HW
    Mol Cells; 2002 Dec; 14(3):339-47. PubMed ID: 12521295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
    Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
    Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide on glutaminergic modulation of dopaminergic activation.
    Hong JT; Kim HC; Kim HS; Lee YM; Oh KW
    Pharmacol Res; 2005 Oct; 52(4):298-301. PubMed ID: 15939623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NMDA receptor in the regulation of plasma interleukin-6 levels in mice.
    Song DK; Suh HW; Jung JS; Wie MB; Song JH; Kim YH
    Eur J Pharmacol; 1996 Dec; 316(2-3):165-9. PubMed ID: 8982683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of MK-801 on contextual sensitization to climbing behavior and on development of tolerance to hypothermia induced by a single high dose of apomorphine.
    Yun JS; Kim HS; Lee MK; Oh KW; Jang CG; Park WK; Seong YH; Lee SC; Oh SK
    Pharmacol Res; 2001 Dec; 44(6):473-9. PubMed ID: 11735353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice.
    Kim HS; Park WK; Jang CG; Oh S
    Brain Res Bull; 1996; 40(3):201-7. PubMed ID: 8736582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors.
    Keyshams N; Zendehdel M; Babapour V; Baghbanzadeh A
    Vet Res Commun; 2016 Jun; 40(2):63-71. PubMed ID: 27000110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study.
    Campos F; Alfonso M; Vidal L; Faro LR; Durán R
    Eur J Pharmacol; 2006 Oct; 548(1-3):90-8. PubMed ID: 16963020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the NMDA-antagonist, MK-801, on stress-induced alterations of dopamine dependent behavior.
    Mele A; Cabib S; Oliverio A
    Psychopharmacology (Berl); 1995 Feb; 117(3):313-7. PubMed ID: 7770607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.